Implanet S.A. (ENXTPA:ALIMP) confirms offer to acquire Orthopaedic & Spine Development for an enterprise value of €4.2 million on March 17, 2021. Implanet S.A. finalized the agreement to acquire Orthopaedic & Spine Development for an enterprise value of €4.3 million on March 30, 2021. Under the terms of agreement, Implanet S.A. will pay €2.665 million in cash and remaining €1.61 million in Implanet securities, €0.5 million of which will be paid on the date of acquisition, and the remainder in the form of a 24-month sales credit guaranteed by a pledge on the OSD shares thus acquired. The transaction will be funded by the bond convertible into shares set up with Nice & Green for a maximum of €5.0 million. The final acquisition percentage will be communicated shortly after finalization of the legal documentation and the founding shareholders of OSD will also become shareholders of IMPANET. The transaction is subject to approval of offer by Implanet S.A shareholder at the Shareholders’ Meeting scheduled for May 5, 2021. Before March 31, 2021, Implanet will convene a General Meeting in order to submit the takeover agreement to its shareholders. As of May 18, 2021 the transaction was approved by Implanet S.A shareholder at the Shareholders’ Meeting. Atout Capital acted as financial advisor to Implanet S.A. Emmanuelle Porte and Sylvie Hamel of Bird & Bird LLP acted as legal advisor to Implanet S.A. Implanet S.A. (ENXTPA:ALIMP) completed the acquisition of Orthopaedic & Spine Development on May 18, 2021.